| A new analytical approach was developed involving magnetic
solid-phase extraction (MSPE) and spectrofluorimetric determination
of propranolol (PRO) in biological fluids. A urine or plasma
sample was prepared and adjusted to pH 3-4, then PRO was quickly
extracted using Fe3O4 magnetic nanoparticles (MNPs) modified by
the surfactant sodium dodecyl sulfate (SDS) and determined applying
spectrofluorimetry. Experimental conditions, such as the amount of
MNPs and SDS, pH value, standing time, desorption solvent and maximal
extraction volume have been adjusted to optimize the extraction
process and to obtain analytical characteristics of the method. Linearity
was observed in the analyte’s concentration range of 2-75 ng mL-1
for both urine and plasma samples. The correlation coefficients (r)
were higher than 0.99. The method showed good precision and accuracy,
with intra- and inter-assay precisions of less than 5.0% at all
concentrations. Standard addition recovery tests were carried out, and
the recoveries ranged from 79.4% to 90.4%. The limits of detection
and quantification were 0.85 and 2.80 ng mL-1, respectively, for urine
and 0.74 and 2.43 ng mL-1, respectively, for plasma. The method was
applied to the determination of PRO in human urine and plasma
samples. |